Intrinsic Value of S&P & Nasdaq Contact Us

Penumbra, Inc. PEN NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
67/100
3/7 Pass
SharesGrow Intrinsic Value
$304.88
-8.2%
Analyst Price Target
$371.92
+12%

Penumbra, Inc. (PEN) has a consensus analyst rating of Hold, based on 22 analysts covering the stock. Of those, 9 recommend buying, 13 recommend holding, and 0 recommend selling.

The analyst consensus price target for PEN is $371.92, representing a +12.0% upside from the current price of $332.17. Price targets range from a low of $349.00 to a high of $388.00.

Analyst Consensus — PEN

Hold
Strong Buy
0
Buy
9
Hold
13
Sell
0
Strong Sell
0
22 analysts
Price Targets
Consensus$371.92
High$388.00
Low$349.00
Median$374.00
Last Month Avg-
Last Quarter Avg$370.45
Last Year Avg$345.76
All-Time Count52
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message